Abstract
British Journal of Cancer (2002) 86, 2–4. DOI: 10.1038/sj/bjc/6600062 www.bjcancer.com
© 2002 The Cancer Research Campaign
MeSH terms
-
Administration, Oral
-
Antineoplastic Agents / administration & dosage*
-
Cisplatin / administration & dosage*
-
Cisplatin / adverse effects
-
Drug Administration Schedule
-
Etoposide / administration & dosage
-
Female
-
Humans
-
Neoplasm Recurrence, Local / drug therapy*
-
Ovarian Neoplasms / drug therapy*
Substances
-
Antineoplastic Agents
-
Etoposide
-
Cisplatin